(Q33853922)

English

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America (English)

1 reference

Europe PubMed Central

29 July 2017

anti-retroviral agent

0 references

Margot B Kushel

object named as

Margot B Kushel

26

0 references

Benigno Rodriguez

object named as

Benigno Rodriguez

17

0 references

object named as

Stephen J Gange

2

0 references

Michael John Gill

object named as

M John Gill

10

0 references

object named as

Robert S Hogg

6

0 references

1

object named as

Steven G Deeks

1 reference

Europe PubMed Central

29 July 2017

Sonia Napravnik

20

object named as

Sonia Napravnik

1 reference

Europe PubMed Central

29 July 2017

7

object named as

Joseph J Eron

1 reference

Europe PubMed Central

29 July 2017

8

object named as

John T Brooks

1 reference

Europe PubMed Central

29 July 2017

19

object named as

Gregory D Kirk

1 reference

Europe PubMed Central

29 July 2017

Mari M Kitahata

3

object named as

Mari M Kitahata

1 reference

Europe PubMed Central

29 July 2017

4

object named as

Michael S Saag

1 reference

Europe PubMed Central

29 July 2017

James J Goedert

27

object named as

James J Goedert

1 reference

Europe PubMed Central

29 July 2017

5

object named as

Amy C Justice

1 reference

Europe PubMed Central

29 July 2017

Michael A Horberg

23

object named as

Michael A Horberg

1 reference

Europe PubMed Central

29 July 2017

Michael J Silverberg

24

object named as

Michael J Silverberg

1 reference

Europe PubMed Central

29 July 2017

9

object named as

Sean B Rourke

1 reference

Europe PubMed Central

29 July 2017

21

object named as

Anita R Rachlis

1 reference

Europe PubMed Central

29 July 2017

Timothy R. Sterling

18

object named as

Timothy R Sterling

1 reference

Europe PubMed Central

29 July 2017

15

object named as

Marina B Klein

1 reference

Europe PubMed Central

29 July 2017

Lisa A. Jacobson

16

object named as

Lisa P Jacobson

1 reference

Europe PubMed Central

29 July 2017

Liviana Calzavara

22

object named as

Liviana M Calzavara

1 reference

Europe PubMed Central

29 July 2017

Constance A. Benson

12

object named as

Constance A Benson

1 reference

Europe PubMed Central

29 July 2017

Rosemary G McKaig

28

object named as

Rosemary G McKaig

1 reference

Europe PubMed Central

29 July 2017

25

object named as

Kelly A Gebo

1 reference

Europe PubMed Central

29 July 2017

13

object named as

Ann C Collier

1 reference

Europe PubMed Central

29 July 2017

author name string

Ronald J Bosch

11

1 reference

Europe PubMed Central

29 July 2017

Jeffrey N Martin

14

1 reference

Europe PubMed Central

29 July 2017

Richard D Moore

29

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

29 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

29 July 2017

49

1 reference

Europe PubMed Central

29 July 2017

10

1 reference

Europe PubMed Central

29 July 2017

1582-1590

1 reference

Europe PubMed Central

29 July 2017

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Maraviroc for previously treated patients with R5 HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Raltegravir with optimized background therapy for resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Treatment of antiretroviral-drug-resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV integrase inhibitors--out of the pipeline and into the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33853922&oldid=1945933867"